EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
We are looking for a new Chemistry curator to join the ChEBI team. Find out more about it here.
CHEBI:48538 - apomorphine
| Formula | C17H17NO2 |
| Net Charge | 0 |
| Average Mass | 267.328 |
| Monoisotopic Mass | 267.12593 |
| SMILES | [H][C@@]12Cc3ccc(O)c(O)c3-c3cccc(c31)CCN2C |
| InChI | InChI=1S/C17H17NO2/c1-18-8-7-10-3-2-4-12-15(10)13(18)9-11-5-6-14(19)17(20)16(11)12/h2-6,13,19-20H,7-9H2,1H3/t13-/m1/s1 |
| InChIKey | VMWNQDUVQKEIOC-CYBMUJFWSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Biological Roles: | dopamine agonist A drug that binds to and activates dopamine receptors. alpha-adrenergic drug Any drug that acts on an α-adrenergic receptor. metabolite Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites. |
| Applications: | neuroprotective agent Any compound that can be used for the treatment of neurodegenerative disorders. emetic Any agent that induces nausea and vomiting. antipsychotic agent Antipsychotic drugs are agents that control agitated psychotic behaviour, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. dopamine agonist A drug that binds to and activates dopamine receptors. alpha-adrenergic drug Any drug that acts on an α-adrenergic receptor. antiparkinson drug A drug used in the treatment of Parkinson's disease. antidyskinesia agent Any compound which can be used to treat or alleviate the symptoms of dyskinesia. vasodilator agent A drug used to cause dilation of the blood vessels. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| apomorphine (CHEBI:48538) has parent hydride aporphine (CHEBI:35643) |
| apomorphine (CHEBI:48538) has role antidyskinesia agent (CHEBI:66956) |
| apomorphine (CHEBI:48538) has role antiparkinson drug (CHEBI:48407) |
| apomorphine (CHEBI:48538) has role antipsychotic agent (CHEBI:35476) |
| apomorphine (CHEBI:48538) has role dopamine agonist (CHEBI:51065) |
| apomorphine (CHEBI:48538) has role emetic (CHEBI:149552) |
| apomorphine (CHEBI:48538) has role neuroprotective agent (CHEBI:63726) |
| apomorphine (CHEBI:48538) has role serotonergic drug (CHEBI:48278) |
| apomorphine (CHEBI:48538) has role vasodilator agent (CHEBI:35620) |
| apomorphine (CHEBI:48538) has role α-adrenergic drug (CHEBI:48539) |
| apomorphine (CHEBI:48538) is a aporphine alkaloid (CHEBI:134209) |
| Incoming Relation(s) |
| apomorphine hydrochloride (CHEBI:31228) has part apomorphine (CHEBI:48538) |
| IUPAC Name |
|---|
| 6aβ-aporphine-10,11-diol |
| Synonyms | Source |
|---|---|
| (−)-10,11-dihydroxyaporphine | ChemIDplus |
| 6a.beta.-aporphine-10,11-diol | ChEMBL |
| (6aR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol | IUPAC |
| APL-130277 | ChEMBL |
| Apomorphin | ChEBI |
| apomorphine | IUPHAR |
| Citations |
|---|